Latest filing published 08 Mar 2023 for Arcutis Biotherapeutics, Inc., €12k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Patricia A. Turney: trading record in brief
Patricia A. Turney, listed as senior executive, appears in our data through filings on Arcutis Biotherapeutics, Inc. shares, published by SEC (Form 4). Between 27 February 2020 and 6 March 2023, the trades on record add up to 15 filings.
Sales make up the whole of the open-market record (8 sales, €105k). Besides market trades, the filings include 5 share grants and 2 option exercises. Since January 2023: no purchases and 4 sales on the market.
The latest filing, published on 8 March 2023, reports an open-market sale of €12k in Arcutis Biotherapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Patricia A. Turney
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 831 shares@ US$15.26352.8% of flowCommon StockSEC:0001567619-23-004669:0
- 18,000 shares0Common StockSEC:0001567619-23-004544:0
- 936 shares@ US$16.16633.3% of flowCommon StockSEC:0001567619-23-004274:0
- 15,331 shares@ US$6.5221.0% of flowCommon StockSEC:0001567619-22-014989:0
- 25,328 shares@ US$6.520.0056% mcap47.6% of flowCommon StockSEC:0001567619-22-007727:0
- 25,328 shares@ US$6.5253.2% of flowCommon StockSEC:0001567619-22-007534:0
- 13,300 shares0Common StockSEC:0001567619-22-006493:0
- 936 shares@ US$17.75275.3% of flowCommon StockSEC:0001567619-22-006227:0
8 of 8 declarations
